FLXN is long from 18.75. The stock is trading at $23.19 as of this writing. The original thesis remains intact.
The new target zone is $38 to $44. However, there are many very near term risks that could cause the stock to pull back. Please remember this is a biotech stock and biotech stocks can be very volatile.
Consider taking partial profits on a 10% tranche right here and consider continuing to hold the remaining 10% as part of your speculative portfolio.
A special note to new subscribers: Please see Trade Management Guidelines for the benefits and how to construct a speculative portfolio.